期刊文献+

格列卫新辅助治疗联合手术切除盆腔恶性胃肠外间质瘤

The Imatinib neoadjuvant therapy and surgical operation of EGIST
原文传递
导出
摘要 目的 探讨恶性盆腔胃肠外间质瘤(EGIST)的临床表现、诊断及治疗.方法 报告本院收治的1例行格列卫联合手术切除治疗的EGIST瘤患者的临床资料及相关文献复习.结果 患者首次剖腹探查不能完整切除肿瘤,活检病理示EGIST,采用格列卫400mg/d,连续服用1个月后,肿瘤大小由19cm×18cm×15cm缩小至15cm×15cm×12cm,体积缩小了40.9%,再次行手术切除成功,术后定期复查均未见转移,术后8年肿瘤复发再次行手术切除.结论 EGIST治疗以手术切除为主;对瘤体巨大的患者采用格列卫新辅助治疗联合手术切除效果更好。 Objectives To investigate the clinical manifestation,diagnosis and treatment of extra-gastrointestinal stromal tumor (EGIST).Methods One patient with EGIST whose tuomor was treated with the imatinib neoadjuvant therapy and then resected;we report the clinical data and related literature review.Results The tumor of EGIST in pathology couldn t could not be excised,then after one month by treated with imatinib (400mg/ day),then the tumor diminished from 19cm × 18cm × 15c to 15cm × 15cm × 12cm,the volume of tumor decreased by 40.9%.The tumor was resected,and the patient didnt did not show any indication of metastasis.After 8 years of post -operation follow-up,the tumor recurred then was resected.Conclusions The treatment of EGIST is given priority to with surgical resection;the huge tuomor was treated with the imatinib neoadjuvant therapy and then rescted.
出处 《国际泌尿系统杂志》 2015年第5期685-687,共3页 International Journal of Urology and Nephrology
关键词 胃肠肿瘤 胃肠道间质肿瘤 Gastrointestinal Neoplasms Gastrointestinal Stromal Tumors
  • 相关文献

参考文献10

  • 1Mazur MT,Clark HB. Gastric stromal tumors: reappraisal of histo-genesis[ J]. Am J Surg Pathol,1983 ,7( 16) :507 -519.
  • 2Schubert ML, Moghimi R. Gastrointestinal stromal tumor( GIST)[J]. Curr Treat Options Gastroenter,2006,9(2) : 181 - 188.
  • 3李俊霞,王化虹,谢鹏雁,刘新光,柳平,余靖.胃间质瘤31例临床分析[J].中华内科杂志,2002,41(11):742-745. 被引量:17
  • 4王全红,张均歆,徐树明,程林仙.胃肠间质瘤[J].肿瘤研究与临床,1998,10(1):61-63. 被引量:19
  • 5Deininger MW, Goldman IM, Melo JV. The molecular biology ofchronic myeloid leukemia[ J]. Blood,2000,96 :3343 -3356.
  • 6Levy AD,Remotti HE,Thompson WM,et al. Gastrointestinal stro-mal tumor : radiologic features with pathologic correlalion [ J ]. Ba-diographics,2003,23 :283 -304,456;quiz 532.
  • 7Bumming P, Andersson J, Meis - Kindblom JM,et al. Neoadju-vant, adjuvant and palliative treatment of gastrointestinal stromaltumors(GIST) with imatinib: a centre - based study of 17 pa-tients [J].BJ C,2003,89:460 -464.
  • 8Jiang WZ,Guan GX,Lu HS,et al. Adjuvant imatinib treat - meritafter R0 resection for patients with high - risk gastrointes - tinalstromal tumors: a median follow - up of 44 months [ J ]. J Surg On-col, 104 :760-764.
  • 9Rubin BP, Singer S, Tsao C, et al. Kit activation is a ubiquitousfeature of gastrointestinal stromal tumors[ J]. Cancer Res,2001,61(22): 8118-8121.
  • 10Reichardt P,Joensuu H,Jean YB. New fronts in the adjuvant treat-ment of GIST[ J]. Cancer Chemother Pharmacol,2013,72:715 - 723.

二级参考文献1

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部